BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12584413)

  • 1. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.
    Boeve B; Dickson D; Duffy J; Bartleson J; Trenerry M; Petersen R
    Eur Neurol; 2003; 49(2):72-8. PubMed ID: 12584413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.
    Josephs KA; Boeve BF; Duffy JR; Smith GE; Knopman DS; Parisi JE; Petersen RC; Dickson DW
    Neurocase; 2005 Aug; 11(4):283-96. PubMed ID: 16093229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy with predominant frontal presentation exhibiting progressive nonfluent aphasia due to crossed aphasia.
    Ono Y; Higashida K; Yoshikura N; Hayashi Y; Kimura A; Iwasaki Y; Yoshida M; Shimohata T
    Neuropathology; 2022 Jun; 42(3):232-238. PubMed ID: 35434847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
    Josephs KA; Duffy JR
    Curr Opin Neurol; 2008 Dec; 21(6):688-92. PubMed ID: 18989114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
    Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
    J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An autopsied case of corticobasal degeneration with onset of nonfluent aphasia revealing symmetrical cerebral involvement].
    Ishihara K; Mimura M; Ishigaki S; Shiota J; Nakano I; Kawamura M
    Brain Nerve; 2012 Aug; 64(8):943-9. PubMed ID: 22868886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of atypical progressive supranuclear palsy.
    Spaccavento S; Del Prete M; Craca A; Loverre A
    Clin Interv Aging; 2014; 9():31-9. PubMed ID: 24368882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
    Morishima R; Bandoh M; Sunami Y; Isozaki E
    Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
    Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
    Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations.
    Karnik NS; D'Apuzzo M; Greicius M
    Neurocase; 2006 Dec; 12(6):332-8. PubMed ID: 17182396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between clinical and pathological diagnoses of CBD and PSP.
    Mizuno T; Shiga K; Nakata Y; Nagura J; Nakase T; Ueda Y; Takanashi Y; Urasaki K; Oyamada Y; Fushiki S; Nishikawa J; Yasuhara M; Nakajima K; Nakagawa M
    J Neurol; 2005 Jun; 252(6):687-97. PubMed ID: 15754090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
    Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
    Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.
    Borroni B; Alberici A; Agosti C; Cosseddu M; Padovani A
    Int Psychogeriatr; 2009 Jun; 21(3):463-8. PubMed ID: 19323870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical overlap between the corticobasal degeneration syndrome and other diseases of the frontotemporal spectrum: three case reports.
    Raggi A; Marcone A; Iannaccone S; Ginex V; Perani D; Cappa SF
    Behav Neurol; 2007; 18(3):159-64. PubMed ID: 17726244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.
    Rohrer JD; Paviour D; Bronstein AM; O'Sullivan SS; Lees A; Warren JD
    Mov Disord; 2010 Jan; 25(2):179-188. PubMed ID: 20077483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy.
    Duvoisin RC; Golbe LI; Lepore FE
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):547-54. PubMed ID: 3315157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
    Burrell JR; Ballard KJ; Halliday GM; Hodges JR
    J Alzheimers Dis; 2018; 61(2):705-715. PubMed ID: 29254097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.